[
    [
        {
            "time": "",
            "original_text": "分拆上市规则落地11月记：11家子公司IPO受理，成大生物有望饮“头啖汤”",
            "features": {
                "keywords": [
                    "分拆上市",
                    "规则落地",
                    "子公司IPO",
                    "成大生物"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "分拆上市规则落地11月记：11家子公司IPO受理，成大生物有望饮“头啖汤”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]